Springhill Fund Asset Management (HK) Co Ltd
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Mar 31, 2025, never from the firm's own description.
Closest benchmark: every 13F filer's combined book, active share 98.4%; sector active share 83.0% against the combined 13F book's sector weights.
Over time 2 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
18 tracked positions · as of Mar 31, 2025 · Δ vs Dec 31, 2024Portfolio Trend
Sector Breakdown
As of Mar 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 93.7% | $15,769,012 |
| Unclassified | 6.3% | $1,066,799 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | +48,900 | 78,500 | $2,119,500 | |
| — | +18,065 | 19,858 | $1,418,854 | ||
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | 124,307 | $2,397,882 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2,600 | $1,648,998 | |
| NBIX | Neurocrine Biosciences Inc | 13,612 | $1,505,487 | |
| JAZZ | Jazz Pharmaceuticals plc | 9,853 | $1,223,249 | |
| ARGX | Argenx SE | 1,146 | $678,277 | |
| LLY | ELI LILLY & Co | 816 | $673,942 | |
| PTGX | Protagonist Therapeutics, Inc | 12,859 | $621,861 | |
| TGTX | Tg Therapeutics, Inc. | 13,500 | $532,305 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 7,076 | $363,494 | |
| ASND | Ascendis Pharma A/S | 2,173 | $338,683 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 6,277 | $332,492 | |
| BNTX | BioNTech SE | 3,000 | $273,180 | |
| — | 5,897 | $260,235 | ||
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LEGN | Legend Biotech Corp | 190,800 | $6,208,632 | |
| CYTK | Cytokinetics Inc | 130,735 | $6,149,774 | |
| VERA | Vera Therapeutics, Inc. | 109,400 | $4,626,526 | |
| — | 83,800 | $3,523,790 | ||
| CGEM | Cullinan Therapeutics, Inc. | 276,400 | $3,366,552 | |
| DYN | Dyne Therapeutics, Inc. | 131,200 | $3,091,072 | |
| NRIX | Nurix Therapeutics, Inc. | 160,500 | $3,023,820 | |
| DRUG | Bright Minds Biosciences Inc. | 60,648 | $2,184,540 | |
| BCYC | Bicycle Therapeutics PLC | 116,400 | $1,629,600 | |
| ABVX | Abivax S.A. | 207,600 | $1,519,632 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
NEW | 124,307 | $2,397,882 | 14.24% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Added | 78,500 | $2,119,500 | 12.59% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
NEW | 2,600 | $1,648,998 | 9.79% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
NEW | 13,612 | $1,505,487 | 8.94% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 19,192 | $1,464,157 | 8.70% | |
|
|
Added | 19,858 | $1,418,854 | 8.43% | ||
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
NEW | 9,853 | $1,223,249 | 7.27% | |
|
|
Reduced | 19,925 | $806,564 | 4.79% | ||
| ARGX |
Argenx SE
Healthcare
|
NEW | 1,146 | $678,277 | 4.03% | |
| LLY |
ELI LILLY & Co
Healthcare
|
NEW | 816 | $673,942 | 4.00% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
NEW | 12,859 | $621,861 | 3.69% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
NEW | 13,500 | $532,305 | 3.16% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
NEW | 7,076 | $363,494 | 2.16% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
NEW | 2,173 | $338,683 | 2.01% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
NEW | 6,277 | $332,492 | 1.97% | |
| BNTX |
BioNTech SE
Healthcare
|
NEW | 3,000 | $273,180 | 1.62% | |
|
|
NEW | 5,897 | $260,235 | 1.55% | ||
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 29,491 | $176,651 | 1.05% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.